Jane Street
NNNN icon

Jane Street’s Anbio Biotechnology NNNN Stock Holding History

Jane Street’s Portfolio NNNN Stock Details NNNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$104K Buy
+16,506
New +$140K ﹤0.01% 10574

Other funds holding NNNN

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
SPL
Superior Planning, LLC San Diego, California $240M AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
Ameritas Advisory Services
Ameritas Advisory Services Lincoln, Nebraska $5.22B AUM 19.55% 1-Year Est. Return
Larson Financial Group
Larson Financial Group St Louis, Missouri $4.11B AUM 23.62% 1-Year Est. Return
EverSource Wealth Advisors
EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return

Jane Street's NNNN Position: Q3 2026 in Review

Jane Street opened a new position in Anbio Biotechnology (NNNN) in Q3 2026: 16,506 shares worth $104K. The stake represents ﹤0.01% of the portfolio and ranks #10574 among its holdings.

12 funds tracked by Wall St. Rank hold NNNN as of Q3 2026.

  • Jane Street held 16,506 shares of Anbio Biotechnology worth $104K as of Q3 2026.
  • Anbio Biotechnology was a new Jane Street position in Q3 2026.
  • Anbio Biotechnology made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #10574 holding.
  • 12 funds tracked by Wall St. Rank held Anbio Biotechnology as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.